Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of compound heterozygous SDHA variants on mitochondrial function in pediatric with neurological disease

  • Garrido-Moraga, Rocío
  • Serrano-Lorenzo, Pablo
  • Esteban-Amo, María J.
  • Bellusci, Marcello
  • de la Fuente, Miguel Á.
  • Arenas, Joaquín
  • González-Quintana, Adrián
  • Ugalde, Cristina
  • Simarro, María
  • Martín, Miguel A.
This study examines two rare compound heterozygous missense variants in the SDHA gene, c.1535G > A (p.R512Q) and c.1753C > T (p.R585W), identified in a pediatric patient presenting with neurological manifestations, including epilepsy, developmental delay, and optic atrophy. The SDHA gene encodes a key component of succinate dehydrogenase (SDH), an essential enzyme complex at the intersection of two fundamental metabolic pathways: the Krebs cycle, and the mitochondrial respiratory chain (MRC). Patient-derived fibroblasts were used to evaluate the impact of the mutations on SDH activity and MRC assembly and function. The analysis revealed significant decreases in SDH activity and subunit levels, as well as impaired assembly. Additionally, complex I (CI) activity and CI-containing supercomplexes formation were also impaired, indicating more widespread mitochondrial dysfunction. Unexpectedly, basal and maximal respiration rates remained unchanged, though spare respiratory capacity was significantly reduced. These findings demonstrate the deleterious effects of the c.1535G > A and c.1753C > T variants, which had previously been associated with primary mitochondrial disorder (PMD) and tumors but had not been functionally validated until now, This research was funded by the Instituto de Salud Carlos III, (ISCIII) and the Ministerio de Ciencia e Innovación (Madrid, Spain; co-funded by European Regional Development Fund “A way to make Europe”), grant number PI21/00381 to M.A.M. This work was also partially funded by the Agencia Estatal de Investigación, Grant Number PID2023- 150506OB-I00., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares - líneas celulares primarias
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

  • Bujan, Nuria
  • Morén, Constanza|||0000-0001-6848-7407
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Blázquez, Alberto|||0000-0002-6479-3615
  • Carnicer, Clara
  • Cortés Rodríguez, Ana Belén|||0000-0003-0675-6485
  • González, Cristina
  • López-Gallardo, Ester
  • Lozano, Ester|||0000-0002-6307-9807
  • Moliner, Sonia
  • Gort, Laura|||0000-0003-4746-1034
  • Tobías, Ester|||0000-0002-9968-3651
  • Delmiro, Aitor
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Fernández-Moreno, Miguel Ángel|||0000-0002-3461-0726
  • Ruiz-Pesini, Eduardo|||0000-0002-0269-7337
  • García Arumí, Elena|||0000-0003-1848-005X
  • Rodríguez Aguilera, Juan Carlos|||0000-0002-3371-4128
  • Garrabou, Glòria|||0000-0001-8973-9933
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.